New drug IM-101 aims to tame muscle weakness in myasthenia gravis
Disease control
Recruiting now
This study tests a new medicine called IM-101 in adults with myasthenia gravis, a disease that causes muscle weakness. The trial has two parts: first, checking safety and the right dose in people with a certain antibody; second, testing how well it works in more patients. About 9…
Phase: PHASE1, PHASE2 • Sponsor: ImmunAbs Inc. • Aim: Disease control
Last updated May 04, 2026 16:24 UTC